News

Elekta‘s integrated Oncology Information Systems features a complete, patient-centric chart optimized for medical oncology, radiation oncology and comprehensive practices. Elekta claims MOSAIQ’s single-database EHR can perform clinical decision

The study recruited around 579 patients and has evaluated the efficacy and tolerability of various doses of CRTH2 antagonist in adult patients who were suffering from seasonal allergic

The CHMP positive opinion is based on three pivotal, Phase 3 head-to-head trials that evaluated the effectiveness of XGEVA versus Zometa (zoledronic acid) at delaying skeletal-related events (SREs).

Mylan‘s Divalproex Sodium capsules USP, 125mg are the generic version of Abbott’s Depakote Sprinkle capsules, indicated for the treatment of certain types of seizures. Depakote Sprinkle capsules are

KODAK Security Solutions expertise in material science, digital imaging, document imaging, and graphic communications to create a portfolio of products and technologies that protect against counterfeiting. Kodak Business

Vasolan is a calcium channel blocking agent which suppresses tachyarrhythmia by blocking the influx of calcium ions into cells and slowing cardiac excitation. Currently, Eisai seeks to establish

FAMPYRA is a prolonged-release (sustained release) tablet formulation of the drug fampridine (4-aminopyridine, 4-AP or dalfampridine). The CHMP recommended the conditional marketing authorisation of FAMPYRA to improve walking

Vectura‘s net income operating income was £13.3m, compared to £15.3m for the same period in 2010. The company’s gross profit increased by 10% to £40.2m (2009/10: £36.6m). Vectura

Based on a field alert report for packaging and labeling compliance for unit III, the FDA has asked the company for submitting a detailed action plan on rectifying